跳转至内容
Merck
  • Exercise training combined with antioxidant supplementation prevents the antiproliferative activity of their single treatment in prostate cancer through inhibition of redox adaptation.

Exercise training combined with antioxidant supplementation prevents the antiproliferative activity of their single treatment in prostate cancer through inhibition of redox adaptation.

Free radical biology & medicine (2014-09-23)
Jordan Gueritat, Luz Lefeuvre-Orfila, Sophie Vincent, Armel Cretual, Jean-Luc Ravanat, Arlette Gratas-Delamarche, Françoise Rannou-Bekono, Amélie Rebillard
摘要

In preclinical models, exercise training (ET) or pomegranate juice (PJ) prevents prostate cancer progression. Here, we hypothesized that physical exercise combined with antioxidants could induce synergistic effects through oxidative stress modulation. Forty male Copenhagen rats with prostate tumors were divided into four groups: control, PJ, ET, and PJ+ET. Rats from the PJ group consumed 750 µl of PJ daily, rats from the ET group ran on a treadmill 5 days per week, and PJ+ET rats received the combined treatment. Each week, tumor growth was evaluated. After 4 weeks of treatment, the rats were euthanized and blood, muscles, and tumors were collected. Tumor Ki67, extracellular signal-regulated kinase (ERK) activation, Bcl-2 expression, and enzymatic and nonenzymatic antioxidant defenses, as well as oxidative stress markers (oxidized base, lipid peroxidation, protein carbonylation), were measured. PJ or ET significantly decreased prostate tumor proliferation (Ki67 staining, p<0.05) through the modulation of ERK phosphorylation, whereas the combination of treatments did not limit cancer progression. PJ significantly reduced Bcl-2 expression in tumors (p<0.05) and the combination of PJ and ET prevented this effect. PJ or ET increased enzymatic antioxidant defenses in muscle, PJ increased nonenzymatic antioxidant defenses in plasma and whole blood. In addition, PJ reduced TBARS and 8-oxodGuo levels in tumors as well as ET (p<0.05), whereas protein carbonyl levels were not affected by these two strategies. Paradoxically, association of PJ+ET did not increase antioxidant defenses and no reduction in oxidative stress markers was induced. Loading cancer cells with antioxidants blunts the positive effects of ET and interferes with important reactive oxygen species-mediated physiological processes such as antioxidant adaptations.

材料
货号
品牌
产品描述

Sigma-Aldrich
庚烷, suitable for HPLC, ≥99%
Sigma-Aldrich
高氯酸, ACS reagent, 70%
Sigma-Aldrich
庚烷, ReagentPlus®, 99%
Sigma-Aldrich
庚烷, HPLC Plus, for HPLC, GC, and residue analysis, 99%
Sigma-Aldrich
庚烷, puriss. p.a., reag. Ph. Eur., ≥99% n-heptane basis (GC)
Sigma-Aldrich
高氯酸, 70%, 99.999% trace metals basis
Sigma-Aldrich
高氯酸, ACS reagent, 60%
Sigma-Aldrich
高氯酸, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 70.0-72.0%
Sigma-Aldrich
荧光素, for fluorescence, free acid
Sigma-Aldrich
2,4-二硝基酚, moistened with water, ≥98.0%
Sigma-Aldrich
庚烷, suitable for HPLC, ≥96%
Sigma-Aldrich
高氯酸, 0.1 M
Sigma-Aldrich
庚烷, anhydrous, 99%
Sigma-Aldrich
高氯酸, puriss. p.a., ACS reagent, packed in coated, shock- and leak-protected glass bottle, ≥60% (T)
Sigma-Aldrich
酚红, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
酚红, ACS reagent
Supelco
庚烷, analytical standard
Supelco
庚烷, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
2,4-二硝基酚, PESTANAL®, analytical standard
Supelco
高氯酸溶液, 0.01 M HClO4 in water (0.01N), eluent for IC
Supelco
庚烷, HPLC grade, ≥99%
Sigma-Aldrich
庚烷, SAJ first grade, ≥98.0%
Sigma-Aldrich
2,4-二硝基酚, SAJ special grade, ≥98.0%
荧光素, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
庚烷, JIS special grade, ≥99.0%
Sigma-Aldrich
高氯酸, SAJ super special grade, 60.0-62.0%
Sigma-Aldrich
庚烷, biotech. grade, ≥99%